We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAND
6251
Gladstone Land Corp
LAND
$355M
$1.35M ﹤0.01%
61,081
-39,510
-39% -$1.19M
PDCO
6252
CALL
DELISTED
Patterson Companies, Inc.
PDCO
$1.35M ﹤0.01%
44,700
+5,900
+15% +$185K
EA
6253
DELISTED
Electronic Arts
EA
$1.35M ﹤0.01%
11,120
-23,616
-68% -$3.01M
ORGN
6254
DELISTED
Origin Materials
ORGN
$1.35M ﹤0.01%
8,810
-19,806
-69% -$3.78M
QQQJ icon
6255
CALL
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.19B
$1.35M ﹤0.01%
58,100
+24,100
+71% +$615K
UPLD icon
6256
CALL
Upland Software
UPLD
$13.9M
$1.35M ﹤0.01%
9,300
+4,340
+88% +$634K
VRSK icon
6257
Verisk Analytics
VRSK
$22.9B
$1.35M ﹤0.01%
7,802
+3,823
+96% +$713K
BALL icon
6258
Ball Corp
BALL
$16.2B
$1.35M ﹤0.01%
19,617
+14,151
+259% +$1.07M
ITOT icon
6259
PUT
iShares Core S&P Total US Stock Market ETF
ITOT
$97.9B
$1.35M ﹤0.01%
16,100
-12,400
-44% -$1.13M
CXT icon
6260
CALL
Crane NXT
CXT
$2.9B
$1.35M ﹤0.01%
44,337
-26,486
-37% -$881K
IPAC icon
6261
iShares Core MSCI Pacific ETF
IPAC
$2.78B
$1.35M ﹤0.01%
+25,933
New +$1.45M
ODP
6262
PUT
DELISTED
ODP
ODP
$1.35M ﹤0.01%
44,500
+12,800
+40% +$517K
VICR icon
6263
PUT
Vicor
VICR
$11.7B
$1.35M ﹤0.01%
24,600
+4,300
+21% +$267K
PK icon
6264
PUT
Park Hotels & Resorts
PK
$3.02B
$1.34M ﹤0.01%
99,100
+54,200
+121% +$958K
BCC icon
6265
PUT
Boise Cascade
BCC
$2.86B
$1.34M ﹤0.01%
22,600
-13,800
-38% -$1.02M
SCHQ
6266
Schwab Long-Term US Treasury ETF
SCHQ
$793M
$1.34M ﹤0.01%
33,410
-8,748
-21% -$360K
SRCE icon
6267
1st Source
SRCE
$2.12B
$1.34M ﹤0.01%
29,593
-7,750
-21% -$350K
AIA icon
6268
CALL
iShares Asia 50 ETF
AIA
$5.13B
$1.34M ﹤0.01%
+21,400
New +$1.37M
STEM icon
6269
PUT
Stem
STEM
$58.7M
$1.34M ﹤0.01%
9,375
+2,510
+37% +$417K
ALSN icon
6270
CALL
Allison Transmission
ALSN
$10.5B
$1.34M ﹤0.01%
34,900
-44,300
-56% -$1.69M
BSJQ icon
6271
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$833M
$1.34M ﹤0.01%
60,442
+31,320
+108% +$733K
HDB icon
6272
CALL
HDFC Bank
HDB
$119B
$1.34M ﹤0.01%
48,800
-77,800
-61% -$2.19M
PRI icon
6273
CALL
Primerica
PRI
$9.54B
$1.34M ﹤0.01%
11,200
+2,500
+29% +$314K
AVXL icon
6274
CALL
Anavex Life Sciences
AVXL
$298M
$1.34M ﹤0.01%
133,800
-25,000
-16% -$237K
PCH
6275
CALL
DELISTED
PotlatchDeltic
PCH
$1.34M ﹤0.01%
30,300
+14,200
+88% +$733K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.